Galapagos' FLORA: Highly Positive Hints In IPF, But More To Prove

 
• By Alexandra Shimmings

Mid-stage research in idiopathic pulmonary fibrosis is getting interesting, with Galapagos' GLPG1690 the second novel treatment to report promising data in the space of a few days. Blockbuster sales await.

Lungs
• Source: Shutterstock

More from Clinical Trials

More from R&D